Adcock Richard 4
4 · ImmunityBio, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Adcock Richard
DirectorCEO & President
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-05−83,334→ 0 total→ Common Stock (83,334 underlying) - Tax Payment
Common Stock
2024-02-05$4.04/sh−43,165$174,387→ 243,138 total - Exercise/Conversion
Common Stock
2024-02-05+83,334→ 286,303 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award vested in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares vested on the third anniversary of the vesting commencement date, such that all shares were vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award was February 5, 2021.